Skip to main content
. Author manuscript; available in PMC: 2024 Jan 1.
Published in final edited form as: Parkinsonism Relat Disord. 2022 Dec 7;106:105235. doi: 10.1016/j.parkreldis.2022.105235

Table 1.

Demographics and clinical characteristics of fallers and non-fallers.

Metric Non-fallers (N=90) Fallers (N=54) p-Value
Age (yrs) 67.25 (8.08) 70.81 (7.56) 0.0228
Height (cm) 172.42 (9.93) 174.41 (10.03) 0.1706
Weight (kg) 80.29 (18.75) 78.94 (14.03) 0.9897
Sex (F/M) 35/55 16/38 0.2607
Disease Duration (years) 5.3 (4.1) 7.6 (5.9) 0.0241
Total LEDD (mg/day) 577.79 (337.22) 645.59 (449.11) 0.5820
MDS UPDRS Part II Total Score 11.9 (6.5) 16.0 (7.0) 0.0013
MDS UPDRS Part III Total Score 37.3 (10.9) 46.2 (13.3) 0.0001
MDS UPDRS Part III PIGD Score 4.1 (2.6) 6.5 (3.3) 0.0000
MDS UPDRS Part IV Total Score 3.04 (3.08) 3.87 (3.68) 0.1688
MDS UPDRS Total Score 61.9 (17.5) 77 (22.2) 0.0003
Hoehn & Yahr scale (stage) 2.1 (0.5) 2.5 (0.8) 0.0011
MOCA (score) 25.9 (3.4) 25.7 (3.6) 0.8245
NFOGQ Past Month (score) 0.28 (0.5) 0.6 (0.5) 0.0002
PDQ39 Total Score (%) 15.1 (10.5) 21.4 (12.8) 0.0055

MSD-UPDRS = Movement Disorders Society Unified Parkinson’s Disease Rating Scale; PIGD = Postural Instability and Gait Disorders; NfoGQ = New Freezing of Gait Questionnaire; MOCA = Montreal Cognitive Assessment; LEDD = Levodopa Equivalent Daily Dose; NFOGQ Past Month= First question of NFOGQ for freezing in last month; PDQ39 = Parkinson’s Disease Questionnaire – 39.